High-risk Medulloblastoma—Balancing the High Stakes of Molecular Profiling to Enhance Treatment Responsivity

JOURNAL ARTICLE published 1 September 2021 in JAMA Oncology

Authors: Allison M. Martin | Sadhana Jackson

On Diction

JOURNAL ARTICLE published 1 October 2021 in JAMA Oncology

Authors: Brian R. Smith

Changes to Model Assumptions of the Cost-effectiveness of Durvalumab Therapy for Non-Small Cell Lung Cancer—In Reply

JOURNAL ARTICLE published 1 July 2019 in JAMA Oncology

Authors: Steven D. Criss | Meghan J. Mooradian | Chung Yin Kong

Taxane Followed by Anthracycline or Vice Versa: Impact of Sequential Order on Breast Cancer Recurrence?

JOURNAL ARTICLE published 1 March 2018 in JAMA Oncology

Authors: Kadri Altundag

Moving Toward Economically Sustainable Value-Based Cancer Care in the Academic Setting

JOURNAL ARTICLE published 1 December 2015 in JAMA Oncology

Authors: Joseph Alvarnas | Guy R. Majkowski | Alexandra M. Levine

Screening for COVID-19 in Asymptomatic Patients With Cancer in a Hospital in the United Arab Emirates

JOURNAL ARTICLE published 1 October 2020 in JAMA Oncology

Authors: Humaid O. Al-Shamsi | Eric A. Coomes | Sadir Alrawi

Defining the Impact of Adjuvant Therapy in Molecularly Defined Subsets of Gastrointestinal Stromal Tumor

JOURNAL ARTICLE published 1 May 2017 in JAMA Oncology

Authors: Michael C. Heinrich | Christopher L. Corless | George D. Demetri

Associations Between Parkinson Disease and Cancer in US Asian Americans

JOURNAL ARTICLE published 1 August 2016 in JAMA Oncology

Authors: D. Michal Freedman | Ruth M. Pfeiffer

Direct-to-Consumer Drug Advertising in Oncology Is Not Beneficial to Patients or Public Health

JOURNAL ARTICLE published 1 November 2016 in JAMA Oncology

Authors: Lowell E. Schnipper | Gregory A. Abel

Forging a Path for Metformin Use in Inoperable Locally Advanced Non–Small Cell Lung Cancer

JOURNAL ARTICLE published 1 September 2021 in JAMA Oncology

Authors: Chukwuka Eze | Claus Belka | Farkhad Manapov

To Treat or Not to Treat Men With Low-risk or Intermediate-risk Prostate Cancer—Weighing the Evidence

JOURNAL ARTICLE published 16 June 2022 in JAMA Oncology

Authors: Susan Halabi | Bradley C. Carthon | Wm Kevin Kelly

Association of Adjuvant Immunotherapy Duration With Chronic Immune-Related Adverse Events

JOURNAL ARTICLE published 1 October 2021 in JAMA Oncology

Authors: Elie Rassy | Barbara Pistilli | Caroline Robert

AIO INTEGA Provides Further Support for Immunotherapy in Patients With Advanced ERBB2-Positive Gastroesophageal Adenocarcinoma

JOURNAL ARTICLE published 1 August 2022 in JAMA Oncology

Authors: Monica Patel | Nataliya Uboha

Affiliation Added

JOURNAL ARTICLE published 1 April 2019 in JAMA Oncology

Missing Conflict of Interest Disclosure

JOURNAL ARTICLE published 1 October 2018 in JAMA Oncology

Incorrect Trial Database Number

JOURNAL ARTICLE published 1 November 2017 in JAMA Oncology

Error in the Figure

JOURNAL ARTICLE published 1 December 2019 in JAMA Oncology

Current Challenges Associated With Next-Generation Sequencing of Breast Cancer—Reply

JOURNAL ARTICLE published 1 September 2017 in JAMA Oncology

Authors: Polly Niravath | Burcu Cakar | Matthew Ellis

Independent Oncology Practices in the COVID-19 Era—Does US Cancer Care Need a Bailout?

JOURNAL ARTICLE published 1 March 2021 in JAMA Oncology

Authors: Zachary A. K. Frosch | Lawrence N. Shulman | Justin E. Bekelman

Highlights

JOURNAL ARTICLE published 1 July 2019 in JAMA Oncology